Neuroimmunology Research. A Report from the Cuban Network of Neuroimmunology.
María de Los Angeles Robinson-AgramonteLourdes Lorigados PedreOrlando Ramón Serrano-BarreraPublished in: Behavioral sciences (Basel, Switzerland) (2018)
Neuroimmunology can be traced back to the XIX century through the descriptions of some of the disease’s models (e.g., multiple sclerosis and Guillain Barret syndrome, amongst others). The diagnostic tools are based in the cerebrospinal fluid (CSF) analysis developed by Quincke or in the development of neuroimmunotherapy with the earlier expression in Pasteur’s vaccine for rabies. Nevertheless, this field, which began to become delineated as an independent research area in the 1940s, has evolved as an innovative and integrative field at the shared edges of neurosciences, immunology, and related clinical and research areas, which are currently becoming a major concern for neuroscience and indeed for all of the scientific community linked to it. The workshop focused on several topics: (1) the molecular mechanisms of immunoregulation in health and neurological diseases, (like multiple sclerosis, autism, ataxias, epilepsy, Alzheimer and Parkinson’s disease); (2) the use of animal models for neurodegenerative diseases (ataxia, fronto-temporal dementia/amyotrophic lateral sclerosis, ataxia-telangiectasia); (3) the results of new interventional technologies in neurology, with a special interest in the implementation of surgical techniques and the management of drug-resistant temporal lobe epilepsy; (4) the use of non-invasive brain stimulation in neurodevelopmental disorders; as well as (5) the efficacy of neuroprotective molecules in neurodegenerative diseases. This paper summarizes the highlights of the symposium.
Keyphrases
- multiple sclerosis
- drug resistant
- amyotrophic lateral sclerosis
- cerebrospinal fluid
- temporal lobe epilepsy
- healthcare
- white matter
- multidrug resistant
- acinetobacter baumannii
- mental health
- cerebral ischemia
- public health
- primary care
- autism spectrum disorder
- mild cognitive impairment
- early onset
- cognitive decline
- intellectual disability
- pseudomonas aeruginosa
- binding protein
- climate change
- human health